| [1] |
尹如铁，李克敏，李玉玲，等．罕见类型的子宫颈癌诊治进展[J]．西部医学，2014，26(5)：537–540.
|
| [2] |
Bansal S，Lewin SN，Burke WM，et al.Sarcoma of the cervix: natural history and outcomes[J]. Gynecol Oncol, 2010，118(2)：134–138.
|
| [3] |
NCCN Clinical Practice guidelines in Oncology: uterine sarcoma(2014)EB/OL. National Comprehensive Cancer Network，Inc.
URL
|
| [4] |
Chin PS，Chia YN，Lim YK.et al.Diagnosis and management of Müllerian adenosarcoma of the uterine cervix[J]. Int J Gynecol Obstet, 2013，121(3)：229–232.
|
| [5] |
Bernard B, Clarke BA, Malowany JI, et al. Uterine adenosarcomas: a dual-institution update on staging, prognosis and survival[J]．Gynecol Oncol，2013，131(3): 634–639
|
| [6] |
Yulan MU, Ming LIU, Min SHI, et al. Clinical analysis of alveolar soft tissue sarcoma of the uterine cervix: a case report[J]. Chin Med J, 2010，123(12)：1612–1614.
|
| [7] |
Hasegawa K，Ichikawa R，Ishii R，et al. A case of primary alveolar soft part sarcoma of the uterine cervix and a review of the literature[J]．Int J Clin Oncol, 2011, 16(6)：751–758.
|
| [8] |
Zaloudek CJ, Norris HJ. Adenofibroma and adenosarcoma of the uterus: a cliniopathologic study of 35 cases[J]. Cancer，1981，48(2)：354–366.
|
| [9] |
Clement PB, Scully RE. Mullerian adenosarcoma of the uterus: a clinicopathologic analysis of 100 cases with a review of the literature[J]. Hum Pathol，1990，21(4)：363–381.
|
| [10] |
NCCN Clinical Practice Guidelines in Oncology: soft tissue sarcoma(2014)[EB/OL]. National Comprehensive Cancer Network，Inc.
URL
|
| [11] |
Tanner EJ, Toussaint T, Leitao MM, et al. Management of uterine adenosarcomas with and without sarcomatous overgrowth[J]. Gynecol Oncol, 2013, 129(1)：140–144.
|
| [12] |
Arend R, Bagaria M, Lewin SN, et al. Long term outcome and natural history of uterine adenosarcomas[J]. Gynecol Oncol，2010，119(2)：305–308.
|
| [13] |
Schroeder BA, Rodler ET, Loggers ET，et al.Clinical benefitof trabectedin in uterine adenosarcoma[J]．Med Oncol, 2013，30(2)：501–503.
|
| [14] |
Stacchiotti S，Negri T，Zaffaroni N, et al.Sunitinib in advanced alveolar soft part sarcoma：evidence of a direct antitumor effect[J]. Ann Oncol, 2011，22(7)：1682–1690.
|
| [15] |
Carroll A，Ramirez PT，Westin SN，et al. Uterine adenosarcoma: an analysis on management, outcomes, and risk factors for recurrence[J]. Gynecol Oncol, 2014，135(3)：455–461.
|
| [16] |
Zhou M, Zhao G，Zhao F，et al. Alveolar soft part sarcoma: a clinicopathological analysis of 21 cases[J]. J Clin Exp Pathol, 2010, 26(1)：63–66.
|